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Aims: Coronary artery disease (CAD) and stroke share a major linkage at the chromosome 12q24 locus. The same
chromosome region entails at least a major risk gene for type 2 diabetes (T2D) within NIDDM2, the non-insulin-
dependent-diabetes 2 locus. The gene of Proteasome Modulator 9 (PSMD9) lies in the NIDDM2 region and is
implicated in diabetes in mice. PSMD9 mutations rarely cause T2D and common variants are linked to both late-
onset T2D and maturity-onset-diabetes of the young (MODY3). In this study, we aimed at determining whether
PSMD9 is linked to macrovascular pathology of T2D.
Methods and Results: In our 200 T2D families from Italy, we characterized the clinical phenotype of
macrovascular pathology by defining the subjects for presence or absence of CAD, stroke and/or transitory
ischemic attacks (TIA), plaques of the large arterial vessels (macro-vasculopathy) and arterial angioplasty
performance. We then screened 200 T2D siblings/families for PSMD9 +nt460A/G, +nt437C/T and exon E197G A/G
single nucleotide polymorphisms (SNPs) and performed a non-parametric linkage study to test for linkage for
coronary artery disease, stroke/TIA, macro-vasculopathy and macrovascular pathology of T2D. We performed 1,000
replicates to test the power of our significant results. Our results show a consistent significant LOD score in linkage
with all the above-mentioned phenotypes. Our 1000 simulation analyses, performed for each single test, confirm
that the results are not due to random chance.
Conclusions: In summary, the PSMD9 IVS3+nt460A/G, +nt437C/T and exon E197G A/G SNPs are linked to CAD,
stroke/TIA and macrovascular pathology of T2D in Italians.
Introduction
Type 2 diabetes (T2D) has long-term complications,
both microvascular and macrovascular. The microvascu-
lar complications entail the diabetic retinopathy, diabetic
neuropathy and diabetic nephropathy. The macrovascu-
lar complications are represented by coronary artery dis-
ease (CAD), stroke, transitory ischemic attacks (TIA),
and atherosclerotic plaques in major arterial vessels.
The history of arterial angioplasty in a patient also
implicates the presence of macro-vasculopathy. Given
the high impact of macrovascular pathology on life qual-
ity and life expectancy, it is quite important to identify
risk genes contributing to such polygenic and complex
phenotype.
Recently, a study reported a significant linkage to cor-
onary artery disease (CAD) [1], myocardial infarction
[1,2], stroke [3] to the chromosomal locus 12q24, within
the NIDDM2 locus in which PSMD9 is located.
PSMD9 unique mutations rarely cause T2D [4]. We
identified a significant linkage of PSMD9 common single
nucleotide polymorphism (SNPs) to late-onset T2D, via
recessive/additive model [5], as well as to early-onset
T2D/MODY3 via additive model in Italians families [6].
The PSMD9 role in beta cell dysfunction and T2D in
mice is known [7].
The aim of the present study was to determine
whether the IVS3+nt460A/G, +nt437C/T and exon
E197G A/G T2D risk (SNPs) of PSMD9 cause evidence
for linkage with other T2D-associated phenotypes such
as CAD, stroke/TIA, vasculopathy and macrovascular
pathology of T2D in Italians.
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Ethical Statement
The subjects were all recruited from Rome, Italy follow-
ing the Helsinki declarationg u i d e l i n e s .S u b j e c t sg a v e
written informed consent and the Penn State College of
Medicine Ethical Committee approved the study.
Families
We previously recruited 200 Italian T2D affected sib-
lings and families with both T2D affected and unaffected
members [8]. We excluded all families with identical
twins, both parents affected and genetic admixture with
no Italians. We confirmed that the families were for at
least three generations Italians. In addition, the Italians
are suitable for genetic studies as they are a homoge-
neous population from a geographically restricted
peninsula.
Clinical Phenotyping
We characterized the family subjects with T2D and
without T2D for presence/absence of coronary arterial
disease (CAD: angina or myocardial infarction/coronary
angioplasty/presence of pathological Q waves on the
electrocardiogram), cerebrovascular events (stroke/tran-
sitory ischemic attacks), vasculopathy (plaque(s) on car-
otid arteries/lower extremities arteries, and/or arterial
angioplasty), and macrovascular pathology (vasculopathy
and/or CAD and/or cerebrovascular events). Phenotypes
of macrovascular pathology are described as unknown if
diagnosis is unclear or data are lacking; subjects are
described as affected if they carry the phenotype under
study and as unaffected if they do not have the pheno-
type. In our 200 Italian families, for each phenotype,
data are less than 100%.
Sequencing
We sequenced the PSMD9 IVS3+nt460/+nt437/E197G
SNPs in all family members. We directly sequenced the
PCR products, status post-purification via EXOSAP-IT
on an automated ABI 3730 Sequencer.
Statistical Analysis
We tested in the 200 Italian families for linkage of the
PSMD9 SNPs with all described phenotypes. The three
SNPs studied are in linkage disequilibrium as previously
shown [4]. The map distance between each SNP pair
given for the linkage analysis was 0.1 cM. We performed
our statistical analysis using the latest version of Merlin
software [9] and the allelic information of a total of 200
genotyped families. Merlin analyzed all the informative
families within this dataset. Non-parametric linkage ana-
lysis was performed for the IVS3+nt460A/G, +nt437C/T
and exon E197G A/G SNPs. Each phenotype was tested
independently using for the above-mentioned three
SNPs the same map distance (cm 139.1, 139.2, 139.3 on
the same chromosome, respectively). Merlin calculated
the linkage score for each of these SNPs in linkage dise-
q u i l i b r i u ma sas i n g l el o c u s ,a si tr e p o r t e do n l yo n e
LOD score per statistical test, which implies that Merlin
considered the SNPs located on a single locus.
All results are reported as LOD scores calculated by
Merlin. For each test performed for each specific pheno-
type, to exclude false positive results, we calculated the
empirical P-value in 1,000 replicates of simulations by
using the gene dropping method: this analysis replaces
real data with simulated data, while maintaining the
pedigree structure, allele frequencies and recombination
fraction. These datasets are generated under the null
hypothesis of no linkage. The empirical P-value for each
phenotype-specific test was calculated based on the P-
v a l u ec o r r e s p o n d i n gt ot h es i n g l eL O Ds c o r eg i v e nb y
M e r l i nf o rt h et h r e eS N P sa n a l y s i sa to n el o c u sa n d
using the same map distance of the real analysis.
Further, the outcome of the simulations was calculated
taking in consideration how many times in 1,000 repli-
cates there was a P-value equal to or smaller than the
P-value of the real analysis.
Results
The LOD scores of the non-parametric linkage analysis,
performed for the various phenotypes, are reported,
jointly for the three tested SNPs, with their correspond-
ing P-value as well as with the results of the 1000 simu-
lations (Table 1). Linkage is shown significantly for the
C A Dp h e n o t y p e ,t h es t r o k e / T I Ap h e n o t y p ea n dt h e
macrovascular pathology phenotype and with a less sig-
nificant empirical P-value with the vasculopathy
phenotype.
Discussion
Our study shows that the PSMD9 IVS3+nt460A/G,
+nt437C/T and exon E197G A/G SNPs studied are in
linkage with CAD, cerebrovascular events, vasculopathy,
and macrovascular pathology. The simulation analyses
rule out false results for the linkage to CAD, stroke and
macrovascular pathology at the significance level of at
least a = 0.005, however the significance level of the
vasculopathy linkage is only at a = 0.053. Thus, PSMD9
or any of its variants contribute to linkage of the
reported phenotypes.
Of note, the potential contribution of intronic variants
to complex disorders such as atherosclerosis and/or
major cardiovascular events is widely accepted.
However, we think it is important to take in consid-
eration that the linkage signal detected for the macro-
vascular pathology phenotypes in our study may indeed
reflect the underlying linkage for T2D [5]. In fact, we
recognize that it is difficult to disentangle associated
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geted at one phenotype only at a time. Despite the
necessity to raise concerns about the potential implica-
tions of the statistical data, we think that it is possible
t h a tag e n er e s p o n s i b l ef o rT 2D is also contributing to
macrovascular disease. This interpretation is based on
the fact that the two complex phenotypes are strongly
associated as well as that the same locus is linked in
multiple studies to T2D [10,11] and macrovascular dis-
ease [3,1].
PSMD9 gene has the potential of having pleiotropic
effects. Recently, we published the contribution of the
same gene to T2D-nephropathy [12], which is a micro-
vascular complication of T2D and is linked to the 12q24
locus [13].
Our results should be replicated in different T2D eth-
nic groups and are of relevance to the T2D families as
well as to the families with macrovascular pathology
without T2D carrying linkage in the chromosome 12q24
locus, which may be explained by the PSMD9 variants,
at least partially. This locus in fact was reported as
linked to macrovascular pathology in other populations
[1-3]. In addition, we hereby prove the strength and
validity of the SNP-based linkage approach in identifying
genes in complex disorders. Microsatellite used mostly
in the past as markers for linkage studies in polygenic
diseases should be revisited, as they may have disem-
powered the linkage strategy. Also, family-based linkage
studies are stronger in their statistical power compared
to association studies. Our Italian family dataset is eth-
nically homogenous, thus it allows significant results to
be revealed. The mechanism by which the PSMD9 pro-
tein may contribute to the macrovascular pathology is
unknown at the present time.
Lifetime expectancy is highly affected by the presence
of atherosclerosis and macrovascular pathology, thus the
impact of the identification of a risk gene to macrovas-
cular pathology is inestimable.
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